Last reviewed · How we verify

NCT05735054

A Novel Technique for Endoscopic Transaxillary Thyroidectomy Comparison

Status unknown Last updated 28 February 2023
What this trial tests

trial testing endoscopic thyroidectomy in Thyroid Diseases in 300 participants. Status unknown.

Timeline
1 January 2021
Primary endpoint
30 December 2022
30 December 2024

Quick facts

Lead sponsorSecond Affiliated Hospital of Xi'an Jiaotong University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment300
Start date1 January 2021
Primary completion30 December 2022
Estimated completion30 December 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Second Affiliated Hospital of Xi'an Jiaotong University

Who can join

16 and older, any sex, with Thyroid Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The clinical data from all except the first 20 cases who underwent our novel transaxillary thyroidectomy were collected retrospectively, while the data from patients who underwent conventional open thyroid lobectomy by same surgeon during the same period were used as a control.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Preliminary report on a novel technique for endoscopic transaxillary thyroidectomy: a case-control study.
    Liu Y, Wang J, Chen S, Lv H, et al · · 2024 · cited 1× · PMID 37983762 · DOI 10.1097/js9.0000000000000885

Verify or expand the search:

Other trials of endoscopic thyroidectomy

Trials testing the same drug.

Other recruiting trials for Thyroid Diseases

Currently open trials in the same condition.

Other Second Affiliated Hospital of Xi'an Jiaotong University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05735054.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing